China · Delayed Price · Currency is CNY Byhealth Statistics
Total Valuation
Byhealth has a market cap or net worth of CNY 19.05 billion. The enterprise value is 14.10 billion.
| Market Cap | 19.05B |
| Enterprise Value | 14.10B |
Important Dates
The next confirmed earnings date is Saturday, March 21, 2026.
| Earnings Date | Mar 21, 2026 |
| Ex-Dividend Date | Apr 22, 2025 |
Share Statistics
Byhealth has 1.68 billion shares outstanding. The number of shares has decreased by -3.13% in one year.
| Current Share Class | 1.68B |
| Shares Outstanding | 1.68B |
| Shares Change (YoY) | -3.13% |
| Shares Change (QoQ) | -11.06% |
| Owned by Insiders (%) | 45.79% |
| Owned by Institutions (%) | 7.54% |
| Float | 887.69M |
Valuation Ratios
The trailing PE ratio is 24.19 and the forward PE ratio is 27.73.
| PE Ratio | 24.19 |
| Forward PE | 27.73 |
| PS Ratio | 3.04 |
| PB Ratio | 1.70 |
| P/TBV Ratio | 2.00 |
| P/FCF Ratio | 17.63 |
| P/OCF Ratio | 15.69 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.48, with an EV/FCF ratio of 13.05.
| EV / Earnings | 18.03 |
| EV / Sales | 2.25 |
| EV / EBITDA | 11.48 |
| EV / EBIT | 15.27 |
| EV / FCF | 13.05 |
Financial Position
The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.95 |
| Quick Ratio | 2.51 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.84 |
| Debt / FCF | 0.96 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.33% and return on invested capital (ROIC) is 11.50%.
| Return on Equity (ROE) | 7.33% |
| Return on Assets (ROA) | 4.08% |
| Return on Invested Capital (ROIC) | 11.50% |
| Return on Capital Employed (ROCE) | 8.10% |
| Weighted Average Cost of Capital (WACC) | 7.24% |
| Revenue Per Employee | 2.12M |
| Profits Per Employee | 264,687 |
| Employee Count | 2,955 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 3.11 |
Taxes
In the past 12 months, Byhealth has paid 191.87 million in taxes.
| Income Tax | 191.87M |
| Effective Tax Rate | 19.03% |
Stock Price Statistics
The stock price has decreased by -7.41% in the last 52 weeks. The beta is 0.61, so Byhealth's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -7.41% |
| 50-Day Moving Average | 12.10 |
| 200-Day Moving Average | 12.00 |
| Relative Strength Index (RSI) | 33.45 |
| Average Volume (20 Days) | 13,468,030 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Byhealth had revenue of CNY 6.27 billion and earned 782.15 million in profits. Earnings per share was 0.47.
| Revenue | 6.27B |
| Gross Profit | 4.25B |
| Operating Income | 923.35M |
| Pretax Income | 1.01B |
| Net Income | 782.15M |
| EBITDA | 1.21B |
| EBIT | 923.35M |
| Earnings Per Share (EPS) | 0.47 |
Balance Sheet
The company has 6.06 billion in cash and 1.03 billion in debt, with a net cash position of 5.02 billion or 3.00 per share.
| Cash & Cash Equivalents | 6.06B |
| Total Debt | 1.03B |
| Net Cash | 5.02B |
| Net Cash Per Share | 3.00 |
| Equity (Book Value) | 11.19B |
| Book Value Per Share | 7.30 |
| Working Capital | 5.03B |
Cash Flow
In the last 12 months, operating cash flow was 1.21 billion and capital expenditures -133.38 million, giving a free cash flow of 1.08 billion.
| Operating Cash Flow | 1.21B |
| Capital Expenditures | -133.38M |
| Depreciation & Amortization | 289.20M |
| Net Borrowing | -523.82M |
| Free Cash Flow | 1.08B |
| FCF Per Share | 0.64 |
Margins
Gross margin is 67.90%, with operating and profit margins of 14.74% and 12.48%.
| Gross Margin | 67.90% |
| Operating Margin | 14.74% |
| Pretax Margin | 16.09% |
| Profit Margin | 12.48% |
| EBITDA Margin | 19.35% |
| EBIT Margin | 14.74% |
| FCF Margin | 17.24% |
Dividends & Yields
This stock pays an annual dividend of 0.36, which amounts to a dividend yield of 3.17%.
| Dividend Per Share | 0.36 |
| Dividend Yield | 3.17% |
| Dividend Growth (YoY) | -60.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 77.59% |
| Buyback Yield | 3.13% |
| Shareholder Yield | 6.24% |
| Earnings Yield | 4.11% |
| FCF Yield | 5.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 1, 2016. It was a forward split with a ratio of 2.
| Last Split Date | Apr 1, 2016 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |